Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis
Public ClinicalTrials.gov record NCT01926028. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1b/2a, Multi-center, Double-blind, Randomized, Placebo-controlled Study of a Single Dose of NDV-3A or NDV-3 Vaccine to Evaluate Safety, Tolerability, Immunogenicity and Efficacy in Preventing Recurrent Vulvovaginal Candidiasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-center, randomized, double-blind, placebo-controlled study intended to assess the safety, tolerability and humoral and cellular immune response over a 12-month period after receiving one dose of either the NDV-3A vaccine, NDV-3 vaccine, or placebo. In addition, the clinical efficacy of NDV-3A vaccine in lowering the recurrence rate of vulvovaginal candidiasis (VVC) in patients with recurrent VVC (RVVC) will be evaluated relative to placebo.
Study identification
- NCT ID
- NCT01926028
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 188 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2013 (Type not available)
- Primary completion
- May 2015 (Actual)
- Completion
- May 2016 (Actual)
- Last update posted
- Jul 18, 2018
2013 – 2016
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Precision Trials LLC | Phoenix | Arizona | 85032 | — |
| Arkansas Women's Center | Little Rock | Arkansas | 72205 | — |
| Women's Health Care Research Corp | San Diego | California | 92123 | — |
| McCann MD Research, Inc. | Torrance | California | 90505 | — |
| Women's Medical Research Group, LLC | Clearwater | Florida | 33759 | — |
| KO Clinical Research, LLC | Fort Lauderdale | Florida | 33316 | — |
| Miami Clinical Research, LLC | Miami | Florida | 33155 | — |
| Community Medical Research | Miami Beach | Florida | 33141 | — |
| Community Medical Research LLC | North Miami | Florida | 33181 | — |
| MedPharmics | Metairie | Louisiana | 70006 | — |
| WSU Physician's Group | Detroit | Michigan | 48201 | — |
| Saginaw Valley Medical Research Group, LLC | Saginaw | Michigan | 48604 | — |
| Lawrence OB/Gyn Clinical Research | Lawrenceville | New Jersey | 08648 | — |
| SUNY Downstate Medical Center | Brooklyn | New York | 11203 | — |
| Suffolk Ob/Gyn | Port Jefferson | New York | 11777 | — |
| Drexel University College of Medicine | Philadelphia | Pennsylvania | 19102 | — |
| Magnolia OB/GYN Research Center, LLC | Myrtle Beach | South Carolina | 29752 | — |
| Advanced Research Associates | Corpus Christi | Texas | 78414 | — |
| Discovery Clinical Trials- HCWC, LLC | Dallas | Texas | 75231 | — |
| TMC Life Research | Houston | Texas | 77054 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01926028, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 18, 2018 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01926028 live on ClinicalTrials.gov.